Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 984 products on this category.

Product data	Purity	Price range	Estimated delivery
Carfilzomib Impurity 59 REF: 4Z-C-121062	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 24 REF: 4Z-E-068037	- - -	To inquire	Thu 19 Dec 24
Olaparib Metabolite M12 REF: 4Z-O-032034CAS: 2514757-44-7	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 18 REF: 4Z-P-196022CAS: 1244949-62-9	- - -	To inquire	Thu 19 Dec 24
Carfilzomib REF: TM-T1795CAS: 868540-17-4	99.6% - 99.84%	52.00 €~176.00 €	Thu 19 Dec 24
Palbociclib Impurity 41 REF: 4Z-P-196048	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 83 REF: 4Z-N-066096CAS: 14235-05-3	- - -	To inquire	Thu 19 Dec 24
Abiraterone Impurity 9 REF: 4Z-A-8246	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 62 REF: 4Z-P-196069	- - -	To inquire	Thu 19 Dec 24
4-Bromo-2-fluorobenzamide REF: 4Z-E-068018CAS: 292621-45-5	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 64 REF: 4Z-C-121067	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 52 REF: 4Z-C-121055CAS: 2049024-27-1	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 56 HCl REF: 4Z-E-068070CAS: 177960-04-2	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 59 REF: 4Z-N-066077	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 41 REF: 4Z-E-068054CAS: 869936-86-7	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 25 REF: 4Z-E-068038CAS: 609783-45-1	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 27 REF: 4Z-N-066043	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 32 REF: 4Z-E-068045CAS: 393-06-6	- - -	To inquire	Thu 19 Dec 24
Palbociclib REF: TM-T1785CAS: 571190-30-2	98% - 99.9%	52.00 €~96.00 €	Thu 19 Dec 24
Nintedanib Impurity 41 REF: 4Z-N-066059CAS: 1895918-24-7	- - -	To inquire	Thu 19 Dec 24

5mg		52.00 €
10mg		73.00 €
25mg		94.00 €
50mg		134.00 €
100mg		176.00 €

Cancer treatment

Carfilzomib Impurity 59

Ref: 4Z-C-121062

Enzalutamide Impurity 24

Ref: 4Z-E-068037

Olaparib Metabolite M12

Ref: 4Z-O-032034

Palbociclib Impurity 18

Ref: 4Z-P-196022

Carfilzomib

Ref: TM-T1795

Palbociclib Impurity 41

Ref: 4Z-P-196048

Nintedanib Impurity 83

Ref: 4Z-N-066096

Abiraterone Impurity 9

Ref: 4Z-A-8246

Palbociclib Impurity 62

Ref: 4Z-P-196069

4-Bromo-2-fluorobenzamide

Ref: 4Z-E-068018

Carfilzomib Impurity 64

Ref: 4Z-C-121067

Carfilzomib Impurity 52

Ref: 4Z-C-121055

Enzalutamide Impurity 56 HCl

Ref: 4Z-E-068070

Nintedanib Impurity 59

Ref: 4Z-N-066077

Enzalutamide Impurity 41

Ref: 4Z-E-068054

Enzalutamide Impurity 25

Ref: 4Z-E-068038

Nintedanib Impurity 27

Ref: 4Z-N-066043

Enzalutamide Impurity 32

Ref: 4Z-E-068045

Palbociclib

Ref: TM-T1785

Nintedanib Impurity 41

Ref: 4Z-N-066059